지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2013.1
- 수록면
- 686 - 689 (4page)
이용수
초록· 키워드
오류제보하기
Purpose: Few reports have been made on the therapeutic effects as well as pathological features of an antithrombin preparation in patients diagnosed with septic disseminated intravascular coagulation (DIC) by the diagnostic criteria for acute DIC. Materials and Methods: A total of 88 sepsis patients who had received inpatient hospital care during the period from January 2000 through December 2008 were divided into two groups, an antithrombin group and a non-antithrombin group, to study the outcomes. Furthermore, the relationship between sepsis-related factors and DIC in 44 patients was studied. Results: The antithrombin group contained 34 patients, and the non-antithrombin group contained 54 patients. The outcomes were significantly better in the antithrombin group. The levels of protein C were low in DIC patients. Conclusion: Our results suggest that early administration of antithrombin might improve outcomes of septic DIC patients in the diagnostic criteria for Japanese Association for Acute Medicine acute DIC.
목차
등록된 정보가 없습니다.
참고문헌 (17)
참고문헌 신청
Baudo F / 1998 / Antithrombin III (ATIII) replacement therapy in patients with sepsis and/or postsurgical complications: a controlled double-blind, randomized, multicenter s
Bernard GR / 2001 / Efficacy and safety of recombinant human activated protein C for severe sepsis / N Engl J Med 344 : 699 ~ 709
Dellinger RP / 2004 / Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock / Crit Care Med 32 : 858 ~ 873
Dellinger RP / 2008 / Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008 / Crit Care Med 36 : 296 ~ 327
Eisele B / 1998 / Antithrombin III in patients with severe sepsis. A randomized, placebo-controlled, double-blind multicenter trial plus a meta-analysis on all randomized, p
Bernard GR / 2001 / Efficacy and safety of recombinant human activated protein C for severe sepsis / N Engl J Med 344 : 699 ~ 709
Dellinger RP / 2004 / Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock / Crit Care Med 32 : 858 ~ 873
Dellinger RP / 2008 / Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008 / Crit Care Med 36 : 296 ~ 327
Eisele B / 1998 / Antithrombin III in patients with severe sepsis. A randomized, placebo-controlled, double-blind multicenter trial plus a meta-analysis on all randomized, p
이 논문의 저자 정보
최근 본 자료
댓글(0)
0